OR WAIT null SECS
Premier Research has announced their acquisition of Camargo Pharmaceutical. Camargo is a global strategy, regulatory, and commercial partner for emerging biopharma companies and has experience in complex development programs and approval pathways that uses their knowledge in areas such as oncology, pediatrics, rare disease, and 505(b)(2) product development.
Premier Research has 26 offices globally with employees currently home-based in all corners of the world.
For more information, click here.